|
WO2021033726A1
|
|
Conversion method, conversion agent, method for producing royal jelly composition, and lactobacillus bacteria
|
|
WO2020196583A1
|
|
Method for producing enzymolyzed honeybee larvae
|
|
WO2020196065A1
|
|
Method for producing royal jelly enzymatic decomposition product, and royal jelly enzymatic decomposition product
|
|
WO2020059828A1
|
|
Biofilm formation inhibitor
|
|
WO2019221078A1
|
|
Stabilization of enzyme-degraded royal jelly
|
|
US2021120853A1
|
|
Stabilization of enzyme-treated royal jelly
|
|
WO2019163785A1
|
|
Method for producing membrane vesicle composition
|
|
TW201932443A
|
|
Novel compound
|
|
CN111655226A
|
|
mTOR inhibitors
|
|
US2020023017A1
|
|
Genome stability enhancer
|
|
WO2018123827A1
|
|
Fermented honey product and production method therefor
|
|
WO2018123828A1
|
|
Fermented product and production method therefor
|
|
WO2018079510A1
|
|
Solid honey production method
|
|
WO2018074327A1
|
|
Mucosal immunomodulator
|
|
WO2018056123A1
|
|
Stable enzyme-decomposed royal jelly granules with improved taste
|
|
WO2018034268A1
|
|
Composition for amelioration of female pattern alopecia
|
|
WO2018016455A1
|
|
Nourishing tonic
|
|
CN109310661A
|
|
Improving blood flow agent, queen bee paste composition and queen bee paste composition manufacturing method
|
|
CN107847528A
|
|
Tired palliative
|
|
EP3299024A1
|
|
Urinary system symptom amelioration agent
|
